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Functional analysis of transcription factor binding
sites in human promoters
Troy W Whitfield1, Jie Wang1, Patrick J Collins2, E Christopher Partridge3, Shelley Force Aldred2,
Nathan D Trinklein2, Richard M Myers3 and Zhiping Weng1*
Abstract
Background: The binding of transcription factors to specific locations in the genome is integral to the
orchestration of transcriptional regulation in cells. To characterize transcription factor binding site function on a
large scale, we predicted and mutagenized 455 binding sites in human promoters. We carried out functional tests
on these sites in four different immortalized human cell lines using transient transfections with a luciferase reporter
assay, primarily for the transcription factors CTCF, GABP, GATA2, E2F, STAT, and YY1.
Results: In each cell line, between 36% and 49% of binding sites made a functional contribution to the promoter
activity; the overall rate for observing function in any of the cell lines was 70%. Transcription factor binding
resulted in transcriptional repression in more than a third of functional sites. When compared with predicted
binding sites whose function was not experimentally verified, the functional binding sites had higher conservation
and were located closer to transcriptional start sites (TSSs). Among functional sites, repressive sites tended to be
located further from TSSs than were activating sites. Our data provide significant insight into the functional
characteristics of YY1 binding sites, most notably the detection of distinct activating and repressing classes of YY1
binding sites. Repressing sites were located closer to, and often overlapped with, translational start sites and
presented a distinctive variation on the canonical YY1 binding motif.
Conclusions: The genomic properties that we found to associate with functional TF binding sites on promoters –
conservation, TSS proximity, motifs and their variations – point the way to improved accuracy in future TFBS
predictions.
Background
The interaction between transcription factor (TF) proteins
and DNA is elementary to the regulation of transcription,
a coordinated process that responds to environmental fac-
tors to achieve temporal and tissue specificity [1,2]. There-
fore, the ability to predict and identify TF binding sites
throughout genomes is integral to understanding the
details of gene regulation and for inferring regulatory net-
works [3]. The list of environmental factors affecting the
transcriptional regulation by a TF includes the binding of
additional TFs [4-6], histone modifications, and chromatin
remodeling.
Due to the importance of identifying transcription fac-
tor binding sites (TFBSs), efforts to identify these sites
computationally are ongoing and intense [3,6-12]. The
most basic elements used for identifying TF binding sites
from sequences are the characteristic binding properties
for each TF, comprising the width of DNA binding site
and the nucleotide preferences at each position. These
properties are quantitatively described by a position
weight matrix (PWM) [13] and can be deduced from
aligning a set of DNA sequences that are experimentally
known to bind the TF. Used on their own, single PWMs,
or motifs, typically predict a binding site for every 5 kb of
DNA. In the human genome, we know that the vast
majority of these predicted sites do not function in the
cell. While they can accurately predict in vitro binding
[14], position weight matrices represent the in vivo reality
more accurately when used in concert with additional
knowledge. For example, phylogenetic footprinting [15]
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and cooperativity between transcription factors [4-6]
have been shown to be a useful supplement to known
PWMs.
A major challenge in the effort to map TF binding
sites comprehensively is to complement TFBS predic-
tions with a high-throughput experimental approach
that directly validates the functional contribution made
by transcriptional regulatory motifs [11]. In addition to
validating computationally predicted TF binding sites,
functional tests reveal whether a given binding event has
the effect of activating or repressing transcription. Such
measured functional outcomes of TF binding have direct
implications for biological networks, cell differentiation,
and disease and should inform next-generation algo-
rithms for identification of TF binding sites.
Taking advantage of data generated by the ENCODE
Consortium [16-18], we carried out a large-scale systema-
tic functional analysis, at base-pair resolution, of predicted
TF binding sites in four immortalized human cell lines by
performing transient transfection assays on promoters
[19-22]. To predict TF binding sites, we used high-
throughput chromatin immunoprecipitation with sequen-
cing (ChIP-seq) data that have been collected on a vast
scale by the ENCODE Consortium. Although ChIP-seq
data are a powerful way to map regulatory relationships,
they do not resolve TF-DNA binding footprints at base-
pair resolution. Typical binding regions determined from
ChIP-seq data are on the order of hundreds of base pairs
in size. The direct application of single motifs, represented
as PWMs [13], to scan the sequences is known to be high
resolution but suffers from a high false-positive rate [10].
We have combined ChIP-seq data generated by members
of the ENCODE Consortium [16-18] with PWM searches
using known motifs [23,24] to generate a set of predicted
TF binding sites (see Materials and methods section for
details). The transient transfection promoter activity assay
fuses a putative promoter sequence with a reporter gene
(here, luciferase) in a plasmid construct. The recombinant
plasmid is transfected into mammalian tissue culture cells,
and the activity of the regulatory segment is inferred from
the amount of reporter gene activity that occurs. This
assay connects the promoter sequence with measured
transcriptional activity. Our investigation was focused on
six transcription factors: CTCF, GABP, GATA2, E2F pro-
teins, STAT proteins, and YY1.
The CCCTC binding factor (CTCF), a DNA-binding
protein with 11 zinc finger domains, is the most thor-
oughly characterized insulator-binding protein in humans
[25-27]. While CTCF has been shown to function as an
enhancer blocker [28], it is also known to repress [29] and
activate [30] transcriptional activity. In addition, CTCF has
been shown to play an unusual role in positioning nucleo-
somes [31] and to be important for global chromatin orga-
nization [27]. Given its diversity of function, CTCF,
originally described as a ‘multivalent factor’, [32] appears
to have a special status among transcription factors [26].
The GA-binding protein (GABP) is an ETS family tran-
scription factor that functions as a heterodimer composed
of the DNA-binding GABPa and transcriptionally activat-
ing GABPb subunits [33]. GABP is known to play an
essential role in cell-cycle progression [34], T cell develop-
ment [35] and early mouse embryogenesis [36]. As a tran-
scriptional regulator, GABP is known to be strongly
activating, with tandem GABP binding sites able to initiate
transcription in the absence of other cis elements [37].
GATA proteins form a family of six regulatory proteins,
each with a highly conserved DNA-binding domain con-
taining two zinc fingers that target the DNA sequence (A/
T)GATA(A/G) [38,39]. The GATA proteins are divided
into two subfamilies based on their expression patterns
[40,41]. The subfamily composed of GATA1, -2, and -3
had been categorized as the ‘hematopoietic’ group [41]
due to their regulation of differentiation-specific genes in
hematopoietic stem cells. GATA1 is expressed in cells
from the myeloid lineage, including erythroid cells, eosino-
phils, mast cells, megakaryocytes, and dendritic cells
[42,43], while GATA2 is expressed in a wider variety of
tissues, including hematopoietic progenitors, erythroid
cells, mast cells, megakaryocytes, adipocytes [44], endothe-
lial cells, and embryonic brain cells [42,45,46]. GATA3 is
highly expressed in embryonic brain cells and T lymphoid
cells but has been found in other tissues [45,47]. GATA4,
-5, and -6 have been categorized as the ‘endodermal’
group [41] because they are expressed (in overlapping pat-
terns) in several endoderm-derived tissues including the
heart, gut, lung, and liver [48]; they may be involved in
regulating cardiogenesis and the differentiation of gut
epithelium [42].
The first member of the E2 factor (E2F) transcription
factor family was identified as a protein that activates the
adenoviral E2 gene by binding its promoter [49]. As a
group, the E2F proteins are important regulators of cell
cycle and DNA synthesis [50-54]. Eight members of this
family have been identified based upon sequence homol-
ogy, E2F1-E2F8 [53,54]. The regulatory functions of E2F
proteins are mediated by the Rb family of ‘pocket pro-
teins’: retinoblastoma protein (pRb), p107, and p130
[51-53,55,56]. E2F6-8 lack the Rb protein binding domain
[57], while E2F4 binds to all members of the Rb family;
E2F1-3 bind only to pRB; E2F5 binds to p130. The func-
tional classification of E2F family members aligns with
their respective binding specifiicities for pocket proteins:
E2F1-3 are considered transcriptional activators (their
overexpression can drive quiescent cells into S-phase
[52]); E2F4 and E2F5 are regarded mainly as repressors
[51,57], although recent analysis of E2F4 overexpression
in HeLa cells reveals many upregulated E2F4 target genes
[58]. DNA binding of the E2F6-8 proteins has been
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associated with transcriptional repression [57]. All mem-
bers of the E2F family share a conserved DNA-binding
domain [59,60] and have been reported to bind the same
TTT(C/G)(C/G)CGC motif in vitro [54].
The signal transducer and activator of transcription
(STAT) proteins comprise a family of latent cytoplasmic
signal-dependent transcription factors [61]. Cytoplasmic
STATs can be activated by a wide variety of extracellular
signals such as cytokines, growth factors. and hormones
that bind to specific cell surface receptors, leading to
STAT phosphorylation on a single tyrosine located near
residue 700 [61,62]. STAT-phosphorylating receptors
include Janus kinases and receptor tyrosine kinases (TKs).
Even without ligand-binding events, however, STAT pro-
teins can be phosphorylated by non-receptor TKs [63,64].
Upon phosphorylation, STAT proteins form homo- or
heterodimers via interactions between their respective Src
homology 2 phophotyrosine-binding domains [61,64,65].
STAT dimers then translocate to the nucleus and bind
to their target DNA loci. Seven mammalian STAT pro-
teins, exhibiting differential response to extracellular sig-
nals, have been identified to date: STAT1-4, STAT5A,
STAT5B, and STAT6. Of these, STAT1, STAT3-4,
STAT5A, STAT5B, and STAT6 form homodimers;
STAT1:STAT2, STAT1:STAT3, and STAT5A:STAT5B
heterodimers also form, depending upon the nature and
concentration of signaling moieties [61,62,64,65]. STAT
proteins regulate the expression of genes that are impor-
tant for immune defense, in ammation, antiviral response,
differentiation, proliferation, and apoptosis [61,66]. STAT
homodimers bind to so-called IFN-g stimulated gene
response (GAS) DNA elements (a palindrome, TTN5-
6AA) [61,64,65]. STAT2 is the only STAT protein that
does not bind GAS elements as a homodimer; STAT1:
STAT2 heterodimers associate with p48 (also known as
IRF9) to form the ISGF3 transcription factor complex,
which recognizes IFN-stimulated response element (ISRE)
DNA sequences (AGTTTNNNTTTCC) [65,67-71]. Our
mutagenesis experiments were focused on binding sites
for (STAT1:STAT1) homodimers recognizing GAS
sequences.
Yin Yang 1 (YY1) is a ubiquitously expressed transcrip-
tion factor whose name derives from its ability to function
as an activator, repressor, or initiator of transcription,
depending upon additional regulatory factors [72]: when
first identified, YY1 was found to repress transcription of
the adeno-associated virus when bound to the P5 promo-
ter region but to activate its transcription in the presence
of the adenovirus E1A protein [73]. YY1 is found in both
invertebrates and vertebrates and is highly conserved.
Placental mammals have two YY1 paralogues, YY2 and
reduced expression 1 (REX1), which have been shown to
result from retrotransposition events early in the mamma-
lian lineage [74]. Whereas YY2 binds to YY1 motifs
(AANATGGN(C/G) [75,76]) with greatly reduced affinity
[74], REX1 recognizes motifs that are divergent from
those of YY1 [74]. Based upon these findings, we expect
that our predicted YY1 binding sites will predominantly
be recognized by YY1, rather than its paralogues. It has
been reported from motif analysis of high-throughput
DNA binding data (ChIP-chip) that YY1 binding sites may
be categorized into two distinct classes: one class with
binding sites located downstream of the transcriptional
start site (TSS), overlapping with translational start sites
and another class upstream, or frequently atop, the TSS
[77]; in this work, we find that these two classes map onto
functional categories, with the former being associated
with transcriptional repression and the latter with
activation.
To better understand the functional consequences of TF
binding, both globally and as it relates to the specific tran-
scription factors listed above, we analyzed the results of
transient transfection promoter activity assays carried out
in K562, HCT116, HT1080, and HepG2 cell lines. In each
assay, we compared the activity of the wild-type promoter
construct with that of a mutant promoter construct in
which the predicted TF binding site was abolished (see
Materials and methods section). We observed a functional
contribution of predicted TF binding sites to promoter
activity at a rate of 49% in K562 cells, 38% in HCT116
cells, 36% in HT1080 cells, and 39% in HepG2 cells. Our
data show that, compared with TF binding sites where
function was not observed, sites that were functionally ver-
ified were more conserved and located closer to the TSS.
We discovered that more than one-third of the experi-
mentally verified TF binding sites repressed transcriptional
activity when bound by a TF, and we carried out similar
analyses to discover the patterns that govern the relation-
ship between TF binding and activation versus repression
of transcription.
Results and discussion
As described in the Materials and methods section, high-
throughput ChIP-seq data were used in conjunction with
known specificities (PWMs) to identify putative TF bind-
ing sites on human promoters. The resulting set of pro-
moters was then mutagenized, and transient transfection
promoter activity assays were carried out on both wild-
type and mutant constructs in order to detect significant
differences in transcriptional activity. The mutations were
chosen to abolish TF binding by mutating as many as five
nucleotides in the most informative (that is, making the
greatest contribution to the TF-DNA binding free energy)
positions.
For our purposes, the transient transfection approach
has the benefit that it measures the function of a speci-
fied DNA fragment, thereby making a direct connection
between sequence and function. Another aspect of the
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method, however, is that it removes the promoter from
its native environment. This displacement implies that
long-range regulatory elements are largely missing. Plas-
mids are chromatinized when transfected, yet their chro-
matin structure differs from that of the endogenous
genes and promoters. In spite of this departure in chro-
matin structure, transient transfection reporter assays
often yield tissue-specific information [21,22].
We performed transfection experiments for each pro-
moter (wild-type or mutant) in three biological replicates
and three technical replicates per biological replicate. We
analyzed the resulting reporter data using a t test to detect
mutant transcriptional activity that was significantly differ-
ent from that of the wild type. Binding sites in which the
mutated version had FDR < 0.025 (after correcting for
multiple testing using the Benjamini-Hochberg rule) were
taken to be functionally verified. The verified mutated
binding sites that had lower average luminosities than
their corresponding wild type indicate that these sites
serve to activate transcription, whereas mutated sites with
higher luminosities than the wild type are indicative of a
repressing effect on transcription.
The results were consistent across the different cell lines,
as shown in Figure 1, where the logarithm of the ratio of
mutant to wild type luciferase signal is plotted for pairs of
cell lines. The intensities of luciferase luminosities were
normalized on each plate using all signals, including four
positive and four negative control transfections. Note that
the linear relationship shown in Figure 1 between the
measured transcriptional effect of TFBS disruption in one
cell line with that in another cell line implies an underly-
ing dependence on TF concentration: an n-fold effect in
one cell line is consistently matched to an m-fold effect in
another cell line. When we carried out linear fitting on for
individual transcription factors, we determined that the
slopes (that is, n/m) were different (within the error from
least-squares fitting) for different TFs (Figure S1 in Addi-
tional file 1). In order to make a more direct connection
between measured luciferase signals and in vivo TF con-
centration, we compared measured wild-type luminosities
in different cell lines (Figure S2 in Additional file 1) and
ENCODE Consortium [16-18] RNA sequencing data
(Figure S3 in Additional file 1), finding a (Pearson) correla-
tion coefficient of 0.59.
The Venn diagram in Figure S4 in Additional file 1
summarizes the results of our functional tests in four cell
lines. In total, we assayed 455 putative TF binding sites
across all cell lines and found that 135 sites were not
functionally verified in any cell line. The numbers in par-
entheses in Figure S4 in Additional file 1, (n-activating,
n-repressing), are for binding sites that were consistently
either activating or repressing across all cell types in
which they were functionally verified. For example, in
Figure 1 Pairwise scatter plots for luciferase signals. Plotted is
|log2(IMT/IWT)|, where IMT and IWT are the mutant and wild-type
normalized luminosities, respectively, in four cell lines (K562,
HCT116, HT1080 and HepG2). Experiments plotted are those where
TFBS function was validated in all four cell lines (bullet), three cell
lines (open circle with middle dot), two cell lines (open square with
middle dot) and one cell line (cross). The Spearman correlation
coefficients for experiments carried out in K562 cells with those in
HCT116 cells (a), HT1080 cells (b), and HepG2 cells (c) are 0.57, 0.64
and 0.65, respectively.
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Figure S4 in Additional file 1, there are 63 predicted TF
binding sites that were functional in all four cell lines, 39
of which were associated with ubiquitous activation of
transcription and 23 with ubiquitous repression (here,
and throughout the remainder of the paper, we de ne
‘ubiquitous’ to mean across all four cell lines in our
study). The remaining ubiquitously verified TFBS (for
YY1, bound at the translational start site of the Metaxin-
3 gene) presented cell line-dependent transcriptional
activity: activating effects were observed in the K562,
HT1080, and HepG2 cell lines, and repression was
observed in the HCT116 cell line. The determination of a
transcriptionally activating versus repressing function of
TF binding is not possible with experimental methods
such as ChIP-seq nor by most computational approaches:
these functional data provide new and important infor-
mation for understanding gene regulation at levels of
both individual genes and networks. Table 1 summarizes
our data according to the TFs in our assays. The majority
of the sites in our tests are bound by six TFs: CTCF, E2F
family proteins, GABP, GATA2, STAT1, and YY1 (that
is, the TFBS sequences appear to be directly occupied by
these factors; see Materials and methods section). These
TFs have varying rates of being functional in at least one
cell line, with CTCF, E2F family proteins, GABP, and
GATA2 all exhibiting a functional verification rate of
approximately 60%, while STAT1 and YY1 had their
function verified at rates of 78% and 88%, respectively.
However, compared with the other factors in our experi-
ments, CTCF and GATA2 had a much lower fraction of
functional sites across all four cell lines. In the case of
GATA2, this observed lower rate of ubiquitous function
may be due to the varying expression levels of GATA
family proteins in different cell lines. For example, it has
been reported that HepG2 cells do not express GATA2
or GATA3 [78] but do express GATA4 [79] (these obser-
vations are broadly confirmed by the ENCODE Consor-
tium [16-18] RNA sequencing data reported in Table S2
in Additional file 1). GATA6 is highly expressed in colon
cancer epithelial cells [48], such as HCT-116. Since
CTCF is broadly expressed, the relatively low rate of ubi-
quitous function across all four cell lines may be due to
combinatorial interactions with other TFs. For example,
in Table 2, we note that promoters with a functionally
verified CTCF binding site were significantly enriched in
AP-2, E2F4, GABP, NF-Y, and Pax5 motifs.
None of the binding sites tested for E2F4 and E2F6
showed ubiquitous function across all four cell types. Of
the 12 E2F4 binding sites that were tested, 7 showed
function in at least one cell line: three binding events
lead to activation of transcription, and four lead to tran-
scriptional repression. Of the three E2F6 binding sites
that were tested, two displayed function in at least one
cell type, leading to transcriptional repression in both
cases. Although the total number of E2F family binding
sites tested was relatively few, these results are in line
with the current understanding of the regulatory modes
for E2F4 and E2F6, with the former leading to both acti-
vation and repression of gene expression [58] and the lat-
ter being exclusively repressing [57].
Among the ubiquitously functional sites, a majority of
those for CTCF, GABP, GATA2, and STAT1 have an
activating effect, but only one-third of YY1 sites are acti-
vating. This result is perhaps a surprising one for CTCF,
which is generally regarded as a chromatin organizer [27]
and insulator-binding protein [25-27], but is also known
to act both as a repressor [32] and as an activator [30]. If
CTCF is acting as an insulator, the implication would be
Table 1 Summary of functional tests of 466 predicted TF binding sites in four human cell lines
TF Func. Tested Ubq.Func. Ubq. Act. Ubq. Rep. Func. K562 Func. HCT116 Func HT1080 Func HepG2 PWM AUC
CTCF 104 168 9 9 0 62 52 49 53 Ref. [31] 0.84
E2F4 7 12 0 0 0 3 3 3 0 E2F:4 M00739 0.83
E2F6 2 3 0 0 0 1 0 1 0 E2F:1 M00938 0.78
EGR1 1 2 0 0 0 0 1 0 0 Egr:3 M00245 0.76
GABP 7 11 4 4 0 5 5 6 5 Ref. [103] 0.77
GATA1 4 4 1 1 0 4 4 1 1 GATA:1 M00128 0.69
GATA2 47 80 4 3 1 36 20 18 14 GATA:2 M00348 0.81
JUND 3 3 1 1 0 2 2 1 3 CREBP1 M00041 0.65
MAX 3 3 1 0 1 2 2 2 2 cMycMax M00118 0.77
STAT1 54 69 16 11 5 41 27 29 39 STAT1 M00224 0.74
USF1 2 2 1 1 0 2 2 2 1 USF M00121 0.86
YY1 86 98 26 9 16 63 56 53 58 Ref. [103] 0.82
Total 320 455 63 39 23 221 174 165 176
For each TF that was part of our functional study, columns list the number of functional verifications in at least one cell line, number of TFBSs tested, number of
ubiquitously functional TFBSs, number of ubiquitously activating TFBSs, number of ubiquitously repressing TFBSs, number of TFBSs functionally verified in each cell
line, the source of PWM used and the corresponding AUC when applied ChIP-seq data sets. The PWMs are shown as motif logos in Table S1 of Additional file 1.
Whitfield et al. Genome Biology 2012, 13:R50
http://genomebiology.com/2012/13/9/R50
Page 5 of 16
that disruption of the CTCF binding site leads to a
decreased transcriptional activity via repressive elements
on the same promoter that are no longer under its influ-
ence. The comparison between CTCF and YY1 is shown
in Figure S5 in Additional file 1, where it is clear that
some YY1 sites have strong repressing effects and where
our ubiquitously functional CTCF sites have strong acti-
vating effects. We show below that the repressive YY1
sites are distinguished by their location relative to the
translational start site. Table 3 lists the genes whose
expression was ubiquitously activated and repressed,
respectively in our four cell lines, according to TF.
Of the seven GABP binding sites in which we observed a
functional effect on transcription, all binding events had
an activating effect; the four GABP binding sites with ubi-
quitous function across each of our cell lines were activat-
ing (see Table 3). This observation is consistent with
previous evidence for GABP as a general activator [37,80].
The genes whose transcription is ubiquitously activated by
GABP binding are listed in Table 3. All of these genes are
known targets of the cAMP-response element binding
protein (CREB) [81], a known co-activator of GABP
[82,83].
Ubiquitously activated targets of STAT1 binding listed
in Table 3 include IRF7 and IRF9, both of which are mem-
bers of the interferon regulatory factor family, proteins
involved in immune response. IRF7 and IRF9 are both
known to respond to extracellular signaling (see Table 3).
IRF7 is critical to the type-I interferon (INF-a/b) response
to viral infection [84], while IRF9 (also known as p48)
forms the ISGF3 transcription factor complex with the
STAT1:STAT2 heterodimer to bind ISRE DNA sequences.
Ubiquitously functional targets of YY1 binding are listed
in Table 3 and include genes known not only from pre-
vious ChIP experiments to detect YY1 binding [77], but
also those to detect HNF4a [85] and CREB [81] binding.
This binding is consistent with previous analysis of ChIP-
chip data for YY1, which has revealed a small but statisti-
cally significant enrichment of CREB binding sites within
experimentally determined YY1 binding regions [77].
Moreover, HNF4a is a known transcriptional co-activator
for the CREB-binding protein. Based on these earlier find-
ings, it is reasonable to expect overlapping targets for YY1,
HNF4a , and CREB among our set of functional YY1
binding sites.
We compared the fold change in reporter signal, |log2
(IMT/IWT)|, between different groups of TF binding sites
defined in Figure S6 in Additional file 1, where IMT and
IWT are the mutant and wild-type normalized luminosities,
respectively. As can be seen in Figure S6 in Additional
file 1, TF binding sites that were functionally verified
across all four cell lines showed the highest magnitude in
fold change, statistically different from sites that were not
ubiquitously functional (p < 2 10-16). While the observed
pattern of increasing fold change being associated with
functional verification in a greater number of cell lines
may be biologically important, it may also be that we were
able to detect ubiquitous function more readily in
the binding sites that led to the strongest effects on
transcription.
It is known that human promoters cluster into two
groups based upon normalized CpG content: the high
CpG promoters that are associated with strong expression
across a broad range of cell types and the low CpG pro-
moters that are associated with weaker but tissue-specific
expression [22]. To determine the effect of CpG content
in the wild-type promoter on whether a site is functional,
we compared the CpG content between the promoters
with one or more TFBSs verified in all four cell lines with
those having no functionally verified TFBSs (p = 0.29). We
also compared the promoters with ubiquitously functional
TFBSs to those having a TFBS that was functionally veri-
fied in only one cell line or else not functional (p = 0.23).
In neither comparison did we observe a significant differ-
ence in normalized CpG content.
Groups of binding sites for the same TF, so-called
homotypic clusters of TFBSs (HCTs), have been computa-
tionally detected in the human genome on the basis of
known PWMs [86]. It has been suggested that such homo-
typic clusters may offer mechanistic advantages, or simple
functional redundancy in transcriptional regulation.
Enrichment in HCTs has been found in promoters and
enhancers [86]. In the context of our tests of TFBS func-
tion, one might expect the presence of HCTs to impact
the transcriptional response to the disruption of a single
TFBS, with additional binding sites for the same TF com-
pensating for its loss. Accordingly, we searched our pro-
moter set for HCTs of the assayed TFs. For each of our
putative TF binding sites, we re-scanned its promoter
using the same motif (see Table S1 in Additional file 1 and
Table 1) and score threshold as was used in our predic-
tions. From this re-scanning, we detected up to three
instances of homotypic TFBSs on a single promoter. A
large majority of our promoters, however, contained only
Table 2 Analysis of over- and underrepresented
secondary motifs on promoters
TF TF2 p value
CTCF AP-2 < 0.001
E2F4 < 0.001
GABP 0.031
LBP-1 0.999
NF-Y < 0.001
Pax5 0.046
STAT1 AP-1 < 0.001
Secondary motifs (TF2 column) over- and underrepresented on promoters
with functional TFBSs (TF column) versus promoters with nonfunctional TFBSs
(TF column).
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Table 3 Summary of genes regulated by ubiquitously functional TFBSs for five TFs: CTCF, GABP, GATA2, STAT1, and
YY1
TF Ubiquitously activated Ubiquitously repressed
CTCF AL645504.2
ANKRD46
BICD2
C17orf81
CEP135
CRYAA
EGLN2
POMT2
TSFM
GABP GARTa
PSMB4a
SYNJ1a
ZNF259a
GATA2 CTSH CCM2
PLSCR2
TNFAIP8L1
STAT1 ATG4C HCFC1
DCLRE1C RPS24
DIMT1L TMED5
ELP3 XXbac-
BPG116M5.1
GSTK1 ZNF367
IRF7b
IRF9 b
KIF2A
MTMR9
NMI
SBNO2
YY1 COQ5cd AC091153.1
CPNE1 ATP5O
CPSF2 cd BIRC6d
CR613718 CAPZA2
IP6K2a CXorf26
NARSac DKFZp434H247
PAK4d EFHA1
PSMB4ac MRPS10c
UBR5 MRPS18Bacd
NUP160
OXCT1
PSMD8ac
SNX27
SNX3ad
SRP68ad
TNKS
A composite of RefSeq [104], UCSC known genes [105] and GENCODE [106] annotations were used. The GREAT gene annotation tool [107] was used to compare
our data with results from published experiments: a targets of CREB, identified by ChIP-chip in HEK293T cells in three different time points after forskolin
stimulation [81], b genes upregulated by tamoxifen [108] in HMEC-E6 cells, genes upregulated in Jurkat cells by IFN-a and IFN-b but not by overexpression of a
constitutively active form of IRF3 [109], c targets of YY1 identified by Chip-chip [77], d targets of HNF4a identified by Chip-chip in hepatocytes from TF targets.
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a single homotypic TFBS. For example, of the 168 CTCF
binding sites that were tested (see Table 1), 135 were on
promoters with a unique instance, 32 were on promoters
with two instances, and 1 was on a promoter containing
three instances. For YY1, we functionally tested binding
sites: 88 promoters with a single instance of YY1 binding,
6 with a pair of instances, and 4 with three instances. We
compared the number of homotypic TFBS instances per
promoter between functional classes of TFBSs, observing a
general trend of higher verification rates for promoters
with fewer homotypic TFBSs. This observation, however,
was not statistically significant: p < 0.78 when comparing
promoters having ubiquitously functional CTCF binding
sites to those with ubiquitously unverified predicted CTCF
binding sites. When this same comparison is made for
promoters with predicted YY1 binding sites, p < 0.99.
Functional classes of TFBSs could not be distinguished on
the basis of the number of homotypic binding sites on the
same promoter for any of the TFs in our study. The
response in transcriptional activity implied by multiple
homotypic TFBSs on a given promoter likely depends
upon the details of homotypic TFBS distribution, such as
the conservation at each site, the distance between
instances, and the presence of intervening heterotypic
TFBSs.
Functional analysis of transcription factor co-localization
on promoters
In Table 2, we list secondary TF motifs whose overrepre-
sentation (or underrepresentation) on promoters contain-
ing binding sites for CTCF and STAT1, respectively, can
be related to a functional outcome. The motifs listed in
the ‘TF2’ column of Table 2 are statistically overrepre-
sented (or underrepresented) on promoters with a func-
tional binding site for transcription factors listed in the
‘TF’ column (that is, CTCF and STAT1), relative to pro-
moters with a predicted (CTCF or STAT1) binding site
whose function was not verified. As a starting point for
our analysis, the secondary motifs (TF2) were constrained
to be among those exhibiting statistically significant co-
localization based upon an analysis of 490 ENCODE Con-
sortium [16-18] ChIP-seq data sets. From this analysis of
ChIP-seq data, reported elsewhere [87], 96 heterotypic
motifs were found to be significantly co-localized (the list
of TF motifs that co-localize with those in our functional
study is presented in Table S3 Additional file 1). Focusing
our analysis on motifs that have exhibited co-localization
in large-scale data sets has the advantage of adding confi-
dence to our findings and allows us to use high-quality
motifs, derived from the ChIP-seq experiments. For each
TF with more than 20 predicted binding sites in the pre-
sent study (to ensure statistically reliable results), we tested
for statistical overrepresentation of motifs [9] on promo-
ters with functionally verified (in at least one cell line)
TFBSs versus promoters with TFBSs that were not func-
tionally verified. For GATA2 and YY1, we did not observe
any overrepresented motifs, in the former case due to the
short list of co-localized candidates (see Table S3 in Addi-
tional file 1) and in the latter case due to the high rate of
TFBS function.
We found that several transcription factors, including
AP-2, E2F4, GABP, NF-Y, and Pax5, were overrepresented
on promoters with functional CTCF binding sites, com-
pared with promoters whose predicted CTCF binding sites
were not functionally verified. Motifs for LBP-1, a tran-
scription factor that regulates genes related to growth and
differentiation, are underrepresented on promoters with
functional CTCF binding sites, as indicated by its high p
value (Table 2). Several of the transcription factors that
are overrepresented on promoters with functional CTCF
binding sites, including AP-2, E2F proteins, and GABP,
have recently been reported to be enriched in genomic
loci that are constitutively bound by CTCF across multiple
tissue types in different species (chicken, mouse, and
human) [88]. Our results suggest a transcriptional out-
come for the co-localization of CTCF and these motifs on
promoters.
We find that the transcription factor AP-1 was overre-
presented on promoters with functional STAT1 binding
sites, relative to promoters whose predicted STAT1 bind-
ing sites were not functionally verified. AP-1 has been
identified as a ‘potential collaborating’ factor for STAT1 in
a recent study of microRNA regulation [89].
YY1 exhibits a variant motif for sites where binding
represses transcription
Among the TF binding sites that were ubiquitously
functional, we compared the genomic footprints of sites
where binding activated or repressed transcription in all
four cell lines. Among the transcription factors we
examined (see Table 1), YY1 had the most examples of
each case (9 ubiquitously activating and 16 ubiquitously
repressing sites). Figure 2 shows the motifs derived from
this analysis for YY1. The most striking difference
between the YY1 motif for sites where binding is asso-
ciated with activation (Figure 2b) and those where bind-
ing is associated with repression (Figure 2c) occurs at
position 4, where the G has greater information content
for repressing cases (p < 0.012 using a permutation test,
see Figure S7 in Additional file 1). The repressive YY1
binding sites are closer to translational start sites than
are the activating YY1 binding sites (p = 7.7 × 10-4).
Indeed, 12 of the repressing YY1 binding sites are
located directly over the translational start site, whereas
only a single activating YY1 binding site is. The muta-
genesis experiments reported here elucidate the func-
tional distinction between the different classes of YY1
binding sites that were noted in a previous analysis of
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DNA binding (ChIP-chip) [77]: the class of YY1 binding
sites localized around the translational start site are
strongly associated with transcriptional repression, while
those localized closer to the TSS are associated with
activation.
In Figure 2d, we report the vertebrate phyloP score
[90] for each nucleotide, averaged over sites where YY1
binding results in activation or repression of transcrip-
tion, respectively. Error bars indicate the standard error
of the mean. Conservation is generally high for YY1,
relative to that for the other transcription factors in our
study. At position 4 of the YY1 motif, we observe that
mean conservation is lower among the activating sites
compared with the repressing sites (p < 0.06 using a
Wilcoxon rank sum test). We also note that, while both
activation- and repression-associated classes of YY1
binding sites show greater conservation over the binding
site, relative to flanking regions, the conservation of the
repression-associated class is greater than that of the
activation-associated class, even beyond the 5’ and 3’
ends of the YY1 motif.
Conservation correlates with functional verification rate
Evolutionary constraint is an important factor in disco-
vering functional genomic elements and has been used
not only to identify TF binding sites [15,91,92], but also
to distinguish real motifs from false positives [93]. For
each predicted TFBS, we computed the mean phyloP
score [90] for conservation among vertebrates. In Figure
3, we show that TF binding sites that are functionally
verified in at least a single cell line are more conserved
than those that were not verified in any cell line (p =
6.6 × 10-4).
Distance to the TSS correlates with functional verification
rate
In Figure 4a, the distribution of genomic distance
between TF binding sites and the TSS is compared
between predicted binding sites that were functionally
verified in at least one cell line and those that whose
function could not be verified. We found that functional
TF binding sites tended to be closer to the TSS than
TFBSs with unverified function (p = 1.8 × 10-3).
This result, taken together with our observation of
greater conservation among TF binding sites that are func-
tional across many cell lines, is consistent with earlier find-
ings in human promoters [21,94], where it has been noted
that much of the constraint appears within 50 bp of the
TSS. In Figure 4b, we compared sites where TF binding
consistently implied activation of transcription with those
Figure 2 Characterization of functional YY1 binding sites. Sequence logo [102] for YY1 binding sites from (a) PWM and sites that are
functionally (b) ubiquitously activating (9 BS) or (c) ubiquitously repressive (16 BS) in four human cell lines. In (d), we plot the mean vertebrate
phyloP conservation score [90] around functional YY1 binding sites. The mean score, S¯phyloPvert , was computed at each base for sites where the
binding event ubiquitously activated (black line) or repressed (red line) transcription in all four cell lines. The position weight matrix that was
used to predict YY1 binding sites is shown (scale on the right axis).
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where the effect was consistently repressing. We found
that activating TF binding sites are significantly closer than
repressing TF binding sites to the TSS (p = 4.7 × 10-2).
This observation is not due to the effect of repressing YY1
binding sites being localized on or around the translational
start site. Indeed, removing the YY1 binding sites from the
overall distributions presented in Figure 4b only increases
the significance of the distinction between activating and
repressing TFBSs (p = 7.5 × 10-4). These findings are con-
sistent with those of Cooper et al. [21], who detected posi-
tive elements on human promoters between 40 and 350 bp
away from the TSS, as well as the presence of negative ele-
ments from 350 to 1,000 bp upstream of the TSS.
Conclusions
We have computationally identified 455 putative TF
binding sites and functionally tested them in four
human cell lines using a transient transfection reporter
assay. Overall, 70% of the predicted TF binding sites
were functionally verified in at least one of the four cell
lines that were used in this study. Of 455 sites, 63 (14%)
were verified in all cell lines, 75 (16%) were verified in
three cell lines only, 77 (17%) were verified in two cell
lines only, 105 were verified in only a single cell line
(23%), and 135 (30%) were not functional in any cell
line. For each functionally verified TFBS, we were able
to determine whether binding led to activated or
repressed transcriptional activity in each cell line.
Our large-scale functional tests provide insights into
the biology several transcription factors. For CTCF, we
determined that functional binding sites were located on
promoters for which motifs of the transcription factors
AP-2, E2F4, GABP, NF-Y, and Pax5 were overrepre-
sented and LBP-1 was underrepresented. Similarly, the
AP-1 motif was overrepresented on promoters with
functional STAT1 binding sites. Perhaps more than with
any other transcription factor, our experiments shed
light on YY1 binding with DNA. Two previously identi-
fied classes of YY1 binding sites, characterized by locali-
zation at or near the translational start site on the one
hand and the TSS on the other, have been related to
functional effects on transcription, with the former class
associated with transcriptional repression and the latter
with activation. Moreover, we have detected a signature
Figure 3 Conservation differs for functional classes of TF binding sites. Distributions of normalized vertebrate phyloP score, SphyloPvert . for
TFBSs that were functionally verified in at least one cell line (dashed line) and for TFBSs that were not functionally verified in any cell line (solid
line).
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Figure 4 Using the distance to the TSS to distinguish between TF binding site classes. Binding sites that were functionally verified or not
(a) and between activating and repressing TFBSs (b). Here, P|N| = P-N + PN is the probability of finding a validated TFBS within |N| base pairs of
the transcription start site (inset). The cumulative probability, PM =
∑M
N=0 P|N| , is plotted in the main panels.
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variation in binding motifs for functional classes of YY1
binding sites, with the repressing cases showing a pre-
ference for G at position 4 of the motif (see Figure 2). It
is known that the genomic context of DNA sequences
studied using transient transfection represents a depar-
ture from the native environment. This departure
implies that looping interactions are largely absent, epi-
genomic features such as histone modifications and
even some longer-range cis-regulatory elements may dif-
fer from those in the native chromatin. Nevertheless,
transient transfection has the important advantage of
making a direct link between DNA sequence and func-
tion. From analyzing these functional tests, we deter-
mined that functional TF binding sites tended to be
more conserved and located closer to the TSS than pre-
dicted binding sites whose functional impact on promo-
ter activity was not detected. TF binding sites that were
ubiquitously functional in all four assayed cell lines were
more conserved and located closer to the TSS than sites
that were not functionally verified and sites whose func-
tion was cell line specific. Moreover, among sites that
were ubiquitously functional, those where TF binding
led to repression of transcription were located farther
from the TSS than those where binding led to activa-
tion. Using YY1 as an example, we demonstrated that
activating sites and repressive sites can show an evolu-
tionarily conserved difference in a motif position. Taken
together, these features can be used to improve the
accuracy of TFBS predictions, thereby improving our
ability to construct biological networks.
Finally, the approach that we have taken here to identi-
fying and functionally testing TF binding sites can be
applied in investigating the functional consequences of
variations in sequence and in binding of regulatory ele-
ments among individuals [95] and alleles [96]. At present,
such variations are characterized at the level of ChIP
peaks (hundreds of base pairs) and although such varia-
tions are almost certainly associated with determining
phenotype, the details remain to be described.
Materials and methods
TFBS prediction
We predicted specific binding sites using ChIP-seq data
collected primarily in K562 cells (see Table S4 in Addi-
tional file 1 for data sets used). For each transcription fac-
tor data set, binding regions (or peaks) were called using
MACS [97]. For each peak region, a length-matched
sequence was randomly selected from the unbound (in the
ChIP-seq experiment) regions of the genome; the set of
such unbound sequences comprised our background for
the purposes of testing and comparing PWMs. After
assuming a single (highest scoring) TFBS within each peak
of the ChIP-seq signal (and background sequence), we
used the POSSUM motif scanner [98] with a library of
known PWMs (taken from the TRANSFAC and JASPAR
repositories [23,24] and elsewhere [99]) to scan over each
data set and compared the scores of the peaks with those
from the background sequences. We measured the result-
ing ability of a PWM to discriminate ChIP-seq peaks from
background sequences using the area under (AUC) the
receiver operating characteristic curve. An AUC of 0.5
represents the same ability to discriminate as a random
classifier, while an AUC of 1 represents perfect discrimina-
tion. For each ChIP-seq data set, PWMs were drawn from
the TRANSFAC and JASPAR repositories [23,24], such
that alternative motifs for the corresponding TF and mem-
bers of the same TF family were scanned. For each TF
upon which we carried out TFBS mutagenesis experi-
ments, the most predictive motif (PWM) is shown in
Table 1, along with its corresponding AUC. In a subse-
quent and separate de novo motif discovery analysis [87]
of these same ChIP-seq data sets (and others), we con-
firmed that for each of the TFs appearing in Table 1, the
most significant motif could be assigned directly to that
TF based on a similarity with motifs from the TRANSFAC
and JASPAR repositories [23,24], that is, the ChIP-seq
data sets employed here are dominated by direct TF-DNA
binding for the target TF (see factorbook.org). Indeed, all
of the predictive known motifs listed in Table 1 were
rediscovered through de novo motif analysis, with the
exceptions of E2F4 and E2F6 (see also factorbook.org). In
the cases of E2F4 and E2F6, even when the top-ranked de
novo-discovered motif differed from those listed in Table
1, direct TF-DNA binding by the target TFs was indicated.
Note that, by default, POSSUM computes log-likeli-
hood scores using local nucleotide abundances within a
100-bp window. Adjusting the size of this window had
little effect upon the AUC computed for a given PWM
(see Figure S8 in Additional file 1); the default 100-bp
window size for local abundances was used throughout
this work.
The predicted TF binding sites that resulted from
scanning PWMs over ChIP-seq data sets were distribu-
ted across the human genome. Our functional tests,
however, were carried out exclusively on promoter
sequences from the library of SwitchGear Genomics. In
selecting predicted TF binding sites for assaying biologi-
cal function on promoters, we first restricted our pre-
dicted TFBS list to include only binding sites that
overlapped with the SwitchGear library and applied a
set of additional filters: the log-odds score from PWM
scanning must be at least 10-fold greater than that of
the background for our control set, and the false discov-
ery rate reported for the ChIP-seq peak by MACS [97]
must be less than 0.05. On average, the predicted TF
binding sites were centered on the summits (point of
maximum signal) from the ChIP-seq data (see Figure S9
in Additional file 1).
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For each predicted TFBS that was functionally tested,
mutations were chosen by mutating five nucleotides
such that the binding site match to the PWM was mini-
mized. By comparing the resulting mutated sequence to
a library of known consensus binding sequences, we
ensured that the TFBS was not mutated into a sequence
that was favorable for binding another TF. Data from
our TFBS predictions and measurements are available in
Table 4 in Additional file 2 and will also be made avail-
able at the UCSC Genome Browser [100], for which an
ENCODE page has been developed [101].
Negative controls
Negative control experiments were performed to com-
pare the activities of wild-type promoters with those of
promoters mutated in regions with no expected TF bind-
ing. To locate regions on promoters with no expected TF
binding, ‘unbound’ genomic locations with no measured
ChIP-seq signal in any of the ENCODE Consortium data
sets and no reported hypersensitivity to cleavage by
DNase I (open chromatin) were tabulated (see Table S6
in Additional file 1 for a complete listing of data sets
used to find experimentally unbound genomic regions).
A negative control ‘TFBS’ (12 bp in width) was assigned
at a location chosen randomly (using a uniform distribu-
tion) from within the resulting ‘unbound’ regions. These
control ‘TFBSs’ were randomly mutated at five sites. At
FDR < 0.025, we detected a single functional result from
the 12 negative control binding sites that were assayed in
K562 cells, representing a false positive rate of 8.3%.
Functional tests of putative TF binding sites not bound
in vivo
In addition to our negative controls, we functionally
tested a different class of TF binding sites: sequences
that were predicted to bind TFs based upon scanning
with PWMs but were not observed to be bound in vivo.
We tested 23 sequences that, like our negative controls,
were located in ‘unbound’ genomic locations with no
measured ChIP-seq signal in any of the ENCODE Con-
sortium data sets and no reported hypersensitivity to
cleavage by DNase I (open chromatin). Unlike our nega-
tive controls, however, these sequences were strong can-
didate TFBSs based upon matches to PWMs. These
putative binding sites were identified based on motifs
for CTCF(1), GATA2(2), MAX(1), NFY(1), STAT pro-
teins (17), and USF2(1), where the numbers of binding
sites tested for each motif are indicated in parentheses
(see Table S6 in Additional file 1 for a complete listing
of data sets used to develop the functional tests reported
in this section). We assayed these TF binding sites on
promoter constructs transiently transfected into K562
cells. At the FDR < 0.025 threshold, we detected func-
tion for GATA2(1), NFY(1), and STAT proteins (5), for
an overall functional rate of 30%. This rate of functional
detection is notably lower than that for the predicted
TFBSs that were present within ChIP-seq peaks.
Transient transfection assay
We systematically identified transcription start sites
throughout the genome and have cloned more than
16,000 approximately 1 kb promoter fragments based on
this start site information into a modified version of Pro-
mega’s pGL4.11 firefly luciferase reporter vector. This
clone collection became the starting material for site-
directed mutagenesis using a modified version of the
Quikchange protocol (Agilent Technologies, Inc., Santa
Clara, CA, USA) [101]. All mutants were sequence con-
firmed and then re-arrayed alongside a wild-type control.
Each mutant and accompanying wild-type was then
mini-prepped three times to minimize the possibility that
the variation between sample preparations would result
in a significant difference between wild type and mutant
(see Figure S10 in Additional file 1 for a schematic of our
transient transfection assay).
We optimized transfection conditions for each cell line
independently. The final conditions are described in
Table S7 in Additional file 1. Irrespective of the cell line,
the work flow was similar, save for the differences laid
out in the supplementary table. In brief, after preparing a
master mix containing 3.5 replicates worth of DNA and
transfection reagent and incubating for the recom-
mended amount of time, we added a quantity of freshly
counted cells resuspended in warm, complete media suf-
ficient for 3.5 replicates. After mixing thoroughly, we ali-
quoted the indicated volume into replicate white assay
plates and placed at 37° for 24 h. Thus, each construct
was transfected a total of nine times (three prep repli-
cates each transfected three times). After incubation, the
plates were removed, and SteadyGlo luciferase assay
reagent (Promega Corporation, Madison, WI, USA) was
added to each well. The plates were incubated in the
dark for at least 30 minutes and then read on an LmaxII-
384 luminometer (Molecular Devices, LLC, Sunnyvale,
CA, USA).
Statistical testing
The resulting luminosity data (three transfections, each
with three prep replicates) were analyzed using t tests. A
multiple testing correction was applied to the resulting p
values via the Benjamini-Hochberg rule: in total, there
were 1,855 hypothesis tests from 455 TFBSs tested in
four cell lines, plus 12 negative control experiments in
the K562 cell line and 23 experiments for putative TFBSs
that were unbound in vivo, also in the K562 cellline.
Experiments where FDR < 0.025 for the mutation were
considered to demonstrate TFBS function. All other sta-
tistical comparisons (except where noted) for significant
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differences between distributions were carried out using
the Kolmogorov-Smirnov test, which is appropriate for
detecting differences in two distributions that may have
similar means.
Additional material
Additional file 1: Supplementary Tables S1 to S4 and Figures S1 to
S10, in portable document format (pdf).
Additional file 2: Supplementary Table S5, data from luciferase
assays, in tab-delimited text format.
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